Concepts (250)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vagus Nerve Stimulation | 8 | 2020 | 199 | 2.150 |
Why?
|
| Fibrin | 5 | 2021 | 506 | 1.290 |
Why?
|
| Intracranial Thrombosis | 3 | 2021 | 113 | 1.280 |
Why?
|
| Infarction, Middle Cerebral Artery | 4 | 2012 | 475 | 0.820 |
Why?
|
| Tetanus Toxin | 6 | 2009 | 49 | 0.730 |
Why?
|
| Cerebral Infarction | 3 | 2014 | 1011 | 0.660 |
Why?
|
| Rats, Wistar | 15 | 2014 | 1901 | 0.600 |
Why?
|
| Brain Ischemia | 6 | 2017 | 3265 | 0.580 |
Why?
|
| Positron-Emission Tomography | 6 | 2021 | 6234 | 0.540 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 2 | 2019 | 161 | 0.500 |
Why?
|
| Carotid Artery Thrombosis | 1 | 2014 | 53 | 0.490 |
Why?
|
| Ear, External | 1 | 2014 | 161 | 0.470 |
Why?
|
| Pterygopalatine Fossa | 1 | 2012 | 9 | 0.450 |
Why?
|
| Ganglia, Autonomic | 1 | 2012 | 43 | 0.440 |
Why?
|
| Acetylcholine | 3 | 2006 | 621 | 0.420 |
Why?
|
| Rats | 24 | 2023 | 24260 | 0.420 |
Why?
|
| Radiopharmaceuticals | 1 | 2021 | 2645 | 0.400 |
Why?
|
| Cerebrum | 1 | 2012 | 137 | 0.400 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2021 | 1519 | 0.360 |
Why?
|
| Evans Blue | 1 | 2008 | 45 | 0.330 |
Why?
|
| Vasodilation | 3 | 2004 | 944 | 0.330 |
Why?
|
| Nerve Endings | 2 | 2006 | 109 | 0.320 |
Why?
|
| Peptide Fragments | 7 | 2009 | 5097 | 0.320 |
Why?
|
| Molecular Imaging | 1 | 2014 | 828 | 0.290 |
Why?
|
| Vagus Nerve | 3 | 2020 | 438 | 0.290 |
Why?
|
| Radioisotopes | 2 | 2021 | 499 | 0.280 |
Why?
|
| Synaptic Transmission | 1 | 2012 | 1178 | 0.280 |
Why?
|
| Coloring Agents | 1 | 2008 | 566 | 0.270 |
Why?
|
| Kidney | 4 | 2023 | 7186 | 0.270 |
Why?
|
| Manganese | 2 | 2021 | 408 | 0.270 |
Why?
|
| Calcitonin Gene-Related Peptide | 2 | 2006 | 306 | 0.270 |
Why?
|
| Renal Circulation | 1 | 2006 | 333 | 0.260 |
Why?
|
| Solitary Nucleus | 2 | 2015 | 63 | 0.250 |
Why?
|
| Cortical Spreading Depression | 2 | 2020 | 276 | 0.250 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 3 | 2009 | 65 | 0.240 |
Why?
|
| Cerebrovascular Circulation | 2 | 2012 | 2731 | 0.240 |
Why?
|
| Adenoviridae | 1 | 2008 | 1099 | 0.240 |
Why?
|
| 2-Aminoadipic Acid | 1 | 2023 | 33 | 0.230 |
Why?
|
| Neurons, Afferent | 1 | 2006 | 506 | 0.230 |
Why?
|
| Ischemic Attack, Transient | 1 | 2009 | 935 | 0.230 |
Why?
|
| Nephritis, Hereditary | 1 | 2023 | 88 | 0.220 |
Why?
|
| Heart Rate | 4 | 2019 | 4091 | 0.220 |
Why?
|
| Endothelium, Vascular | 4 | 2006 | 4456 | 0.220 |
Why?
|
| Aldehydes | 1 | 2023 | 167 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2015 | 575 | 0.210 |
Why?
|
| Ganglionic Stimulants | 2 | 1999 | 19 | 0.210 |
Why?
|
| Contrast Media | 5 | 2023 | 5300 | 0.210 |
Why?
|
| Blood-Brain Barrier | 1 | 2008 | 1017 | 0.210 |
Why?
|
| Animals | 35 | 2023 | 168757 | 0.200 |
Why?
|
| Vasodilator Agents | 1 | 2006 | 977 | 0.200 |
Why?
|
| Fibroblast Growth Factor 2 | 2 | 2001 | 599 | 0.200 |
Why?
|
| Gallium Radioisotopes | 1 | 2021 | 178 | 0.190 |
Why?
|
| Organometallic Compounds | 2 | 2023 | 665 | 0.190 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2009 | 1414 | 0.190 |
Why?
|
| Spinal Cord | 5 | 2009 | 1809 | 0.190 |
Why?
|
| DNA Fragmentation | 1 | 2001 | 242 | 0.190 |
Why?
|
| Tissue Distribution | 4 | 2023 | 2327 | 0.180 |
Why?
|
| Superoxide Dismutase | 3 | 2008 | 597 | 0.180 |
Why?
|
| Motor Neurons | 3 | 2009 | 844 | 0.170 |
Why?
|
| Nitroarginine | 3 | 2006 | 66 | 0.170 |
Why?
|
| Biological Factors | 1 | 2000 | 164 | 0.170 |
Why?
|
| Dilatation | 1 | 2000 | 291 | 0.160 |
Why?
|
| Aorta, Abdominal | 1 | 2021 | 646 | 0.160 |
Why?
|
| Electrodes, Implanted | 2 | 2015 | 824 | 0.160 |
Why?
|
| Glycogen Phosphorylase | 1 | 2017 | 16 | 0.160 |
Why?
|
| Indomethacin | 3 | 2006 | 332 | 0.160 |
Why?
|
| Rabbits | 2 | 2021 | 4894 | 0.150 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2008 | 3508 | 0.150 |
Why?
|
| Carotid Arteries | 1 | 2021 | 952 | 0.150 |
Why?
|
| Gadolinium | 4 | 2023 | 952 | 0.140 |
Why?
|
| Nicotine | 2 | 1999 | 681 | 0.140 |
Why?
|
| Scorpion Venoms | 1 | 1996 | 31 | 0.140 |
Why?
|
| Migraine Disorders | 2 | 2020 | 1620 | 0.140 |
Why?
|
| Octoxynol | 2 | 2006 | 77 | 0.130 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2023 | 35421 | 0.130 |
Why?
|
| Nitric Oxide | 2 | 2006 | 2132 | 0.130 |
Why?
|
| Organic Chemicals | 1 | 1996 | 211 | 0.130 |
Why?
|
| Respiratory Mechanics | 1 | 2019 | 686 | 0.130 |
Why?
|
| Low Back Pain | 1 | 2023 | 956 | 0.120 |
Why?
|
| Coordination Complexes | 1 | 2015 | 115 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2001 | 1434 | 0.120 |
Why?
|
| Brain Stem | 1 | 2019 | 846 | 0.110 |
Why?
|
| Locus Coeruleus | 1 | 2014 | 176 | 0.110 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 2006 | 371 | 0.110 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2006 | 491 | 0.110 |
Why?
|
| Male | 25 | 2021 | 350118 | 0.110 |
Why?
|
| Chelating Agents | 1 | 2014 | 380 | 0.110 |
Why?
|
| Analysis of Variance | 3 | 2011 | 6365 | 0.110 |
Why?
|
| Blood Pressure | 3 | 2015 | 8554 | 0.110 |
Why?
|
| Psychomotor Disorders | 1 | 2012 | 152 | 0.100 |
Why?
|
| Recombinant Proteins | 4 | 2009 | 6622 | 0.100 |
Why?
|
| Peptides | 3 | 2014 | 4409 | 0.100 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2009 | 3772 | 0.090 |
Why?
|
| Thrombosis | 3 | 2014 | 2968 | 0.090 |
Why?
|
| Ablation Techniques | 1 | 2012 | 249 | 0.090 |
Why?
|
| Central Nervous System | 2 | 2008 | 1357 | 0.090 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1996 | 1504 | 0.090 |
Why?
|
| Vasoconstrictor Agents | 3 | 1998 | 642 | 0.090 |
Why?
|
| Disease Models, Animal | 5 | 2023 | 18029 | 0.080 |
Why?
|
| alpha-Galactosidase | 1 | 2008 | 57 | 0.080 |
Why?
|
| Lac Operon | 1 | 2008 | 238 | 0.080 |
Why?
|
| Random Allocation | 1 | 2012 | 2429 | 0.080 |
Why?
|
| Drug Delivery Systems | 2 | 2009 | 2219 | 0.080 |
Why?
|
| Brain | 5 | 2023 | 26385 | 0.070 |
Why?
|
| Neuroprotective Agents | 2 | 2006 | 941 | 0.070 |
Why?
|
| Sumatriptan | 2 | 1996 | 65 | 0.070 |
Why?
|
| Glycyrrhetinic Acid | 1 | 2006 | 18 | 0.070 |
Why?
|
| Second Messenger Systems | 1 | 2006 | 206 | 0.070 |
Why?
|
| Capsaicin | 1 | 2006 | 231 | 0.060 |
Why?
|
| Mitomycin | 1 | 2005 | 259 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2021 | 8949 | 0.060 |
Why?
|
| Behavior, Animal | 1 | 2012 | 1881 | 0.060 |
Why?
|
| Perfusion | 2 | 2000 | 1360 | 0.060 |
Why?
|
| Triazines | 1 | 2006 | 315 | 0.060 |
Why?
|
| Functional Laterality | 1 | 2011 | 2290 | 0.060 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2005 | 643 | 0.060 |
Why?
|
| Guanylate Cyclase | 1 | 2004 | 201 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2006 | 689 | 0.060 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2010 | 1442 | 0.060 |
Why?
|
| Carbazoles | 1 | 2004 | 226 | 0.050 |
Why?
|
| Valproic Acid | 1 | 2005 | 445 | 0.050 |
Why?
|
| Motor Activity | 1 | 2012 | 2714 | 0.050 |
Why?
|
| Reperfusion Injury | 1 | 2009 | 1026 | 0.050 |
Why?
|
| Enzyme Inhibitors | 3 | 2006 | 3798 | 0.050 |
Why?
|
| Caspases | 2 | 2005 | 928 | 0.050 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2005 | 333 | 0.050 |
Why?
|
| Protein Biosynthesis | 1 | 2009 | 2126 | 0.050 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2005 | 692 | 0.050 |
Why?
|
| Stroke | 2 | 2017 | 9981 | 0.050 |
Why?
|
| Heterocyclic Compounds | 2 | 2014 | 249 | 0.050 |
Why?
|
| Manganese Compounds | 1 | 2021 | 27 | 0.050 |
Why?
|
| Potassium Channels | 1 | 2004 | 563 | 0.050 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2009 | 2015 | 0.050 |
Why?
|
| Diamines | 1 | 2021 | 59 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 3870 | 0.050 |
Why?
|
| Picolinic Acids | 1 | 2021 | 53 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2008 | 2699 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2014 | 5021 | 0.050 |
Why?
|
| Triazoles | 1 | 2006 | 911 | 0.050 |
Why?
|
| Caspase 1 | 1 | 2001 | 224 | 0.050 |
Why?
|
| Gadolinium DTPA | 1 | 2023 | 836 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2020 | 8301 | 0.040 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2001 | 295 | 0.040 |
Why?
|
| Mice | 8 | 2023 | 81183 | 0.040 |
Why?
|
| Spodoptera | 2 | 2009 | 153 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2009 | 2925 | 0.040 |
Why?
|
| Caspase 3 | 1 | 2001 | 758 | 0.040 |
Why?
|
| Injections, Intravenous | 1 | 2001 | 1420 | 0.040 |
Why?
|
| Female | 11 | 2021 | 380194 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 1 | 2008 | 2716 | 0.040 |
Why?
|
| Injections, Intramuscular | 2 | 2009 | 552 | 0.040 |
Why?
|
| Leg | 1 | 2023 | 1116 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2013 | 1572 | 0.040 |
Why?
|
| Pyrroles | 1 | 2004 | 1146 | 0.040 |
Why?
|
| Phenylephrine | 1 | 1998 | 301 | 0.040 |
Why?
|
| Brain Chemistry | 1 | 2001 | 981 | 0.040 |
Why?
|
| Renal Artery | 1 | 1999 | 398 | 0.040 |
Why?
|
| Internal Mammary-Coronary Artery Anastomosis | 1 | 1996 | 33 | 0.040 |
Why?
|
| Thromboxane-A Synthase | 1 | 1996 | 34 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 15540 | 0.040 |
Why?
|
| Pentanoic Acids | 1 | 1996 | 15 | 0.040 |
Why?
|
| Mammary Arteries | 1 | 1996 | 70 | 0.030 |
Why?
|
| Fibrosis | 1 | 2023 | 2029 | 0.030 |
Why?
|
| Spine | 1 | 2023 | 1144 | 0.030 |
Why?
|
| Muscle Relaxation | 1 | 1996 | 142 | 0.030 |
Why?
|
| Indoles | 1 | 2004 | 1839 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 19905 | 0.030 |
Why?
|
| Receptors, Serotonin | 1 | 1996 | 201 | 0.030 |
Why?
|
| Serotonin Receptor Agonists | 1 | 1996 | 152 | 0.030 |
Why?
|
| Anticonvulsants | 1 | 2005 | 1916 | 0.030 |
Why?
|
| Neurons | 3 | 2005 | 9338 | 0.030 |
Why?
|
| Serotonin | 2 | 1996 | 1017 | 0.030 |
Why?
|
| Heterocyclic Compounds, 1-Ring | 1 | 2014 | 65 | 0.030 |
Why?
|
| Drug Stability | 1 | 2014 | 291 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2006 | 10943 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2011 | 63114 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2001 | 3002 | 0.030 |
Why?
|
| Drug Interactions | 1 | 1998 | 1460 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2017 | 1654 | 0.030 |
Why?
|
| Nitric Oxide Synthase | 1 | 1996 | 916 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 5 | 2009 | 21827 | 0.030 |
Why?
|
| Cerebrovascular Disorders | 1 | 1999 | 1504 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2015 | 1899 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 1996 | 1240 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 20129 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2016 | 1767 | 0.020 |
Why?
|
| Animals, Newborn | 2 | 2006 | 2726 | 0.020 |
Why?
|
| Humans | 11 | 2023 | 744343 | 0.020 |
Why?
|
| Cell Survival | 3 | 2006 | 5882 | 0.020 |
Why?
|
| Aorta, Thoracic | 1 | 1996 | 1082 | 0.020 |
Why?
|
| ROC Curve | 1 | 2017 | 3527 | 0.020 |
Why?
|
| Baculoviridae | 1 | 2009 | 118 | 0.020 |
Why?
|
| Models, Animal | 1 | 2016 | 2171 | 0.020 |
Why?
|
| Time Factors | 2 | 2009 | 40075 | 0.020 |
Why?
|
| Biological Availability | 1 | 2009 | 397 | 0.020 |
Why?
|
| Apoptosis | 2 | 2005 | 9727 | 0.020 |
Why?
|
| Injections, Spinal | 1 | 2009 | 303 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2001 | 4554 | 0.020 |
Why?
|
| Blotting, Western | 2 | 2005 | 5179 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2005 | 12072 | 0.020 |
Why?
|
| Axotomy | 1 | 2006 | 73 | 0.020 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1996 | 2282 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2017 | 2737 | 0.020 |
Why?
|
| Injections, Intraventricular | 1 | 2005 | 230 | 0.020 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2006 | 375 | 0.020 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2005 | 135 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2019 | 6442 | 0.020 |
Why?
|
| Lung | 1 | 2023 | 9856 | 0.020 |
Why?
|
| Mesencephalon | 1 | 2006 | 329 | 0.020 |
Why?
|
| Pyridines | 1 | 1996 | 2825 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2010 | 2203 | 0.010 |
Why?
|
| Cell Line | 2 | 2009 | 15997 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 2006 | 11366 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 14722 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 2009 | 19229 | 0.010 |
Why?
|
| Cell Count | 1 | 2005 | 1856 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2009 | 6314 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2010 | 5078 | 0.010 |
Why?
|
| Protein Transport | 1 | 2006 | 1988 | 0.010 |
Why?
|
| Thrombolytic Therapy | 1 | 2010 | 2161 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2009 | 3420 | 0.010 |
Why?
|
| Dopamine | 1 | 2006 | 1591 | 0.010 |
Why?
|
| Nicotinic Antagonists | 1 | 1999 | 96 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2023 | 53288 | 0.010 |
Why?
|
| Radiography | 1 | 2010 | 7023 | 0.010 |
Why?
|
| Muscarinic Antagonists | 1 | 1999 | 137 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 2006 | 1226 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2005 | 4933 | 0.010 |
Why?
|
| Methiothepin | 1 | 1996 | 1 | 0.010 |
Why?
|
| Ketanserin | 1 | 1996 | 24 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1999 | 2255 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2009 | 9734 | 0.010 |
Why?
|
| Hypertension | 1 | 1996 | 8480 | 0.010 |
Why?
|
| Potassium Chloride | 1 | 1996 | 237 | 0.010 |
Why?
|
| Serotonin Antagonists | 1 | 1996 | 144 | 0.010 |
Why?
|
| United States | 1 | 2023 | 69872 | 0.010 |
Why?
|
| Vascular Patency | 1 | 1996 | 886 | 0.010 |
Why?
|
| Neuroglia | 1 | 1999 | 927 | 0.010 |
Why?
|
| Vasoconstriction | 1 | 1996 | 597 | 0.010 |
Why?
|
| Constriction, Pathologic | 1 | 1996 | 1107 | 0.010 |
Why?
|
| Disease Progression | 1 | 2009 | 13284 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 56430 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 57776 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1996 | 1375 | 0.010 |
Why?
|
| Middle Aged | 3 | 2017 | 213383 | 0.010 |
Why?
|
| Aged | 2 | 2017 | 163280 | 0.000 |
Why?
|
| Adult | 2 | 2019 | 214055 | 0.000 |
Why?
|
| Calcium | 1 | 1999 | 5756 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1999 | 11483 | 0.000 |
Why?
|
| Case-Control Studies | 1 | 1996 | 21746 | 0.000 |
Why?
|
Concepts
(250)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(30)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_